70
Participants
Start Date
September 30, 2016
Primary Completion Date
August 21, 2019
Study Completion Date
January 30, 2023
Oral Glucose Tolerance Test (OGTT)
Subjects will have glucose administered enterally and blood will be drawn to measure its kinetics.
Human Ghrelin
Human ghrelin will be administered by IV at two of the four study visits in conjunction with the OGTT.
Saline
Saline Infusion will be administered by IV at two of the four study visits in conjunction with the OGTT to serve as a placebo comparator for the human ghrelin infusions.
Vanderbilt University Medical Center, Nashville
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Vanderbilt University Medical Center
OTHER